Alta Capital Management LLC lifted its holdings in The Sherwin-Williams Company (NYSE:SHW – Free Report) by 3.0% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 91,024 shares of the specialty chemicals company’s stock after buying an additional 2,622 shares during the quarter. Sherwin-Williams makes up 1.8% of Alta Capital Management LLC’s portfolio, making the stock its 23rd biggest position. Alta Capital Management LLC’s holdings in Sherwin-Williams were worth $31,254,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the business. Vanguard Group Inc. lifted its position in shares of Sherwin-Williams by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 22,082,544 shares of the specialty chemicals company’s stock worth $7,711,004,000 after buying an additional 245,896 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Sherwin-Williams by 21.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 8,657,536 shares of the specialty chemicals company’s stock valued at $3,023,126,000 after purchasing an additional 1,505,341 shares during the last quarter. Alliancebernstein L.P. lifted its position in Sherwin-Williams by 2.2% in the 1st quarter. Alliancebernstein L.P. now owns 4,409,209 shares of the specialty chemicals company’s stock valued at $1,539,652,000 after purchasing an additional 93,209 shares during the last quarter. PineStone Asset Management Inc. lifted its position in Sherwin-Williams by 12.0% in the 2nd quarter. PineStone Asset Management Inc. now owns 1,681,100 shares of the specialty chemicals company’s stock valued at $577,222,000 after purchasing an additional 180,616 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in Sherwin-Williams by 4.4% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,536,398 shares of the specialty chemicals company’s stock valued at $536,495,000 after purchasing an additional 64,325 shares during the last quarter. 77.67% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several analysts recently weighed in on the stock. Wells Fargo & Company set a $395.00 price objective on shares of Sherwin-Williams and gave the company an “overweight” rating in a research report on Friday, October 10th. Loop Capital cut their price objective on shares of Sherwin-Williams from $395.00 to $380.00 and set a “buy” rating on the stock in a research report on Wednesday, July 23rd. JPMorgan Chase & Co. cut their price objective on shares of Sherwin-Williams from $390.00 to $378.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 23rd. Bank of America lowered their target price on shares of Sherwin-Williams from $375.00 to $368.00 and set a “neutral” rating on the stock in a research note on Tuesday. Finally, BMO Capital Markets lowered their target price on shares of Sherwin-Williams from $405.00 to $391.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 23rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Sherwin-Williams has an average rating of “Moderate Buy” and an average price target of $387.13.
Sherwin-Williams Stock Performance
Shares of SHW opened at $332.81 on Thursday. The firm’s 50 day moving average is $354.01 and its 200-day moving average is $348.20. The stock has a market capitalization of $82.98 billion, a P/E ratio of 33.02, a P/E/G ratio of 2.78 and a beta of 1.20. The company has a debt-to-equity ratio of 1.78, a current ratio of 0.78 and a quick ratio of 0.48. The Sherwin-Williams Company has a 12-month low of $308.84 and a 12-month high of $400.42.
Sherwin-Williams (NYSE:SHW – Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The specialty chemicals company reported $3.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.76 by ($0.38). The business had revenue of $6.31 billion during the quarter, compared to analyst estimates of $6.31 billion. Sherwin-Williams had a return on equity of 66.91% and a net margin of 11.03%.The business’s revenue for the quarter was up .6% on a year-over-year basis. During the same period in the prior year, the firm earned $3.70 EPS. Sherwin-Williams has set its FY 2025 guidance at 11.200-11.500 EPS. Equities research analysts anticipate that The Sherwin-Williams Company will post 12 EPS for the current fiscal year.
Insider Activity at Sherwin-Williams
In other news, insider Justin T. Binns sold 609 shares of Sherwin-Williams stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $368.82, for a total value of $224,611.38. Following the transaction, the insider owned 17,922 shares of the company’s stock, valued at $6,609,992.04. The trade was a 3.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CAO James P. Lang sold 860 shares of Sherwin-Williams stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $350.35, for a total transaction of $301,301.00. Following the completion of the transaction, the chief accounting officer directly owned 377 shares in the company, valued at $132,081.95. This represents a 69.52% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.60% of the company’s stock.
About Sherwin-Williams
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Read More
- Five stocks we like better than Sherwin-Williams
- Most Volatile Stocks, What Investors Need to Know
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What is the Nikkei 225 index?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How to Capture the Benefits of Dividend Increases
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Sherwin-Williams Company (NYSE:SHW – Free Report).
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.